6 insiders reported 54 Form 4 transactions for Century Therapeutics, Inc. (IPSC) over the past 18 months (most recent 2026-06-09). Recent activity: Russotti Gregory (See Remarks) Sell 524 shares, Carr Douglas (SVP Finance & Operations) Sell 249 shares, Pfeiffenberger Brent (President and CEO) Sell 463 shares, Pfeiffenberger Brent (President and CEO) Sell 31,172 shares, Cowan Chad (Chief Scientific Officer) Sell 1,365 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-09 | Russotti Gregory | See Remarks | Sell | 524 | $1,106 |
| 2026-06-09 | Carr Douglas | SVP Finance & Operations | Sell | 249 | $526 |
| 2026-06-09 | Pfeiffenberger Brent | President and CEO | Sell | 463 | $986 |
| 2026-05-19 | Pfeiffenberger Brent | President and CEO | Sell | 31,172 | $72,942 |
| 2026-04-03 | Cowan Chad | Chief Scientific Officer | Sell | 1,365 | $2,989 |
| 2026-03-16 | Russotti Gregory | See Remarks | Sell | 10,076 | $25,694 |
| 2026-03-16 | Carr Douglas | SVP Finance & Operations | Sell | 7,043 | $17,960 |
| 2026-03-13 | Cowan Chad | Chief Scientific Officer | Sell | 1,431 | $3,907 |
| 2026-03-13 | Pfeiffenberger Brent | President and CEO | Sell | 55,397 | $151,234 |
| 2026-03-11 | Russotti Gregory | See Remarks | Sell | 479 | $1,217 |
| 2026-03-11 | Carr Douglas | SVP Finance & Operations | Sell | 247 | $627 |
| 2026-03-10 | Pfeiffenberger Brent | President and CEO | Sell | 463 | $1,185 |
| 2026-02-18 | Pfeiffenberger Brent | President and CEO | Sell | 31,172 | $54,551 |
| 2026-02-05 | Carr Douglas | SVP Finance & Operations | Sell | 323 | $588 |
| 2026-02-04 | Pfeiffenberger Brent | President and CEO | Buy | 475,000 | $0 |
| 2026-02-04 | Carr Douglas | SVP Finance & Operations | Buy | 110,000 | $0 |
| 2026-02-04 | Russotti Gregory | See Remarks | Buy | 135,000 | $0 |
| 2026-02-04 | Cowan Chad | Chief Scientific Officer | Buy | 135,000 | $0 |
| 2026-01-06 | Cowan Chad | Chief Scientific Officer | Sell | 1,611 | $1,611 |
| 2025-12-29 | Cowan Chad | Chief Scientific Officer | Buy | 58,060 | $49,351 |
| 2025-12-16 | Pfeiffenberger Brent | President and CEO | Buy | 52,000 | $30,160 |
| 2025-12-12 | Pfeiffenberger Brent | President and CEO | Sell | 463 | $245 |
| 2025-12-10 | Carr Douglas | SVP Finance & Operations | Sell | 257 | $136 |
| 2025-12-10 | Russotti Gregory | See Remarks | Sell | 526 | $279 |
| 2025-11-24 | Cowan Chad | Chief Scientific Officer | Sell | 5,462 | $2,731 |
Source: SEC Form 4 filings · as of 2026-06-09